Singhi Advisors acted as an exclusive M&A and strategic advisor for the acquisition of diagnostics chain Medicentre by India’s fastest growing healthcare platform Redcliffe Labs.

With this acquisition, Redcliffe will get a strong foothold in the Rajasthan market and a stronger base to offer both pathology and imaging tests under one roof.

Redcliffe Labs has become one of India’s leading diagnostic service providers within a span of 4 years and is backed by marquee health-tech investors like *LeapFrog, Chiratae Ventures, HealthQuad* and others.

Medicentre is the largest independent diagnostic lab chain, with 10 labs spread across 5 cities of southern Rajasthan.

Redcliffe’s current offerings include wide-ranged diagnostic testing while Medicentre offers premium-priced category testing, including 3D/4D sonography, CT scan, MRI, Neuro lab, and digital radiography services.   

Until now, Redcliffe has expanded organically to establish a pan-India presence, and Medicentre marks its first major inorganic expansion in India. The deal marks the first inorganic expansion bet by Redcliffe, which operates diagnostic labs across many cities in India. 

Related News